SCOPOLAMINE COOPER 0.5 mg/2 ml, solution for injection 10 ampoules of 2 ml
Active ingredients: Scopolamine hydrobromide, L-scopolamine
Commercialized according to BDPMDispensing in France: Prescription only
Solution for injection10 ampoules of 2 mlsous-cutanée
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- SCOPOLAMINE COOPER 0,5 mg/2 ml, solution injectable
- Pharmaceutical form
- solution injectable
- Route of administration
- sous-cutanée
- Presentation description
- 10 ampoule(s) en verre de 2 ml
- Marketing authorisation holder
- COOPER (ABRÉGÉ DE COOPERATION PHARMACEUTIQUE FRANCAISE)
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 24 Feb 1999
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
64665646CIP73476329CIP133400934763298Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| BROMHYDRATE DE SCOPOLAMINEsolution | 0,5 mg · une ampoule | SA |
| SCOPOLAMINEsolution | 0,35 mg · une ampoule | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.